FDA Inspection 1267912 - Wuhan Biocause Pharmaceutical Development Co., Ltd. - March 14, 2025

Record Details

This FDA Inspection record concerns Wuhan Biocause Pharmaceutical Development Co., Ltd., with an inspection on March 14, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Wuhan Biocause Pharmaceutical Development Co., Ltd.
Inspection Date: March 14, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations

Open in Dashboard

ID · cf0802f0-fbd5-4ef6-8a2f-51da576523d8